Plain-English translation of NCT06241963 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called high-definition transcranial direct current stimulation (HD-tDCS) for people with refractory epilepsy—meaning seizures that don't respond well to standard medications. HD-tDCS uses gentle electrical currents applied to the scalp to stimulate specific brain regions. Researchers want to see whether this treatment can reduce how often seizures happen and how severe they are.
Many people with epilepsy continue having seizures even while taking multiple medications, and they need new options. This medication-resistant form of epilepsy significantly impacts quality of life, so researchers are exploring whether non-invasive brain stimulation might help where drugs alone have failed.
You likely qualify if…
You likely don't qualify if…
You'll visit the research center for treatment sessions over 10 consecutive workdays. Depending on which group you're assigned to, you'll receive either one or two 30-minute sessions per day, where small electrical stimulation pads are placed on your scalp. Before treatment starts and after it ends, you'll complete brain scans, EEG recordings, and thinking/memory tests. The researchers will follow up with you 4 weeks and 12 weeks after your final treatment session to see how you're doing.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
China